Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers

被引：53

作者：

Pillow, Thomas H. ^{[1
]}

Schutten, Melissa ^{[1
]}

Yu, Shang-Fan ^{[1
]}

Ohri, Rachana ^{[1
]}

Sadowsky, Jack ^{[1
]}

Poon, Kirsten Achilles ^{[1
,4
]}

Solis, Willy ^{[1
,5
]}

Zhong, Fiona ^{[1
]}

Del Rosario, Geoffrey ^{[1
]}

Go, Mary Ann T. ^{[1
]}

Lau, Jeffrey ^{[1
]}

Yee, Sharon ^{[1
]}

He, Jintang ^{[1
]}

Liu, Luna ^{[1
]}

Ng, Carl ^{[1
]}

Xu, Keyang ^{[1
]}

Leipold, Douglas D. ^{[1
]}

Kamath, Amrita V. ^{[1
]}

Zhang, Donglu ^{[1
]}

Masterson, Luke ^{[2
]}

Gregson, Stephen J. ^{[2
]}

Howard, Philip W. ^{[2
]}

Fang, Fan ^{[3
]}

Chen, Jinhua ^{[3
]}

Gunzner-Toste, Janet ^{[1
]}

Kozak, Katherine K. ^{[1
]}

Spencer, Susan ^{[1
]}

Polakis, Paul ^{[1
]}

Polson, Andrew G. ^{[1
]}

Flygare, John A. ^{[1
]}

Junutula, Jagath R. ^{[1
,6
]}

机构：

[1] Genentech Inc, San Francisco, CA 94030 USA

[2] Spirogen Ltd, QMBInnovat Ctr, London, England

[3] WuXi AppTec Co Ltd, Shanghai, Peoples R China

[4] Denali Therapeut, San Francisco, CA USA

[5] Bristol Myers Squibb, Princeton, NJ USA

[6] Cellerant Therapeut, San Carlos, CA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2017年 / 16卷 / 05期

关键词：

BIOLOGICAL EVALUATION; TARGETED TREATMENT; CANCER-THERAPY; IN-VIVO; DESIGN; CHEMISTRY; SELECTION; STABILITY; LYMPHOMA; DELIVERY;

D O I：

10.1158/1535-7163.MCT-16-0641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A novel disulfide linker was designed to enable a direct connection between cytotoxic pyrrolobenzodiazepine (PBD) drugs and the cysteine on a targeting antibody for use in antibody-drug conjugates (ADCs). ADCs composed of a cysteine-engineered antibody were armed with a PBD using a self-immolative disulfide linker. Both the chemical linker and the antibody site were optimized for this new bioconjugation strategy to provide a highly stable and efficacious ADC. This novel disulfide ADC was compared with a conjugate containing the same PBD drug, but attached to the antibody via a peptide linker. Both ADCs had similar efficacy in mice bearing human tumor xenografts. Safety studies in rats revealed that the disulfide-linked ADC had a higher MTD than the peptide-linked ADC. Overall, these data suggest that the novel self-immolative disulfide linker represents a valuable way to construct ADCs with equivalent efficacy and improved safety. (C) 2017 AACR.

引用

页码：871 / 878

页数：8

共 50 条

[1] Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates
Marvin, Christopher C.
Hobson, Adrian D.
Mcpherson, Michael
Dunstan, Theresa A.
Vargo, Thomas R.
Hayes, Martin E.
Fettis, Margaret M.
Bischoff, Agnieszka
Wang, Lu
Wang, Lu
Hernandez Jr, Axel
Jia, Ying
Oh, Jason Z.
Tian, Yu
BIOCONJUGATE CHEMISTRY, 2023, 34 (10) : 1835 - 1850
[2] Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
Edupuganti, Veera V. Shivaji R.
Tyndall, Joel D. A.
Gamble, Allan B.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (04) : 479 - 497
[3] A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates
Wei, Ding
Mao, Yurong
Wang, Huihui
Qu, Siqi
Chen, Jiakang
Li, Jiusheng
Jiang, Biao
Chen, Hongli
CHINESE CHEMICAL LETTERS, 2023, 34 (05)
[4] A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates
Ding Wei
Yurong Mao
Huihui Wang
Siqi Qu
Jiakang Chen
Jiusheng Li
Biao Jiang
Hongli Chen
Chinese Chemical Letters, 2023, 34 (05) : 525 - 529
[5] Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers
Gregson, Stephen J.
Masterson, Luke A.
Wei, Binqing
Pillow, Thomas H.
Spencer, Susan D.
Kang, Gyoung-Dong
Yu, Shang -Fan
Raab, Helga
Lau, Jeffrey
Li, Guangmin
Phillips, Gail D. Lewis
Gunner-Toste, Janet
Safina, Brian S.
Ohri, Rachana
Darwish, Martine
Kozak, Katherine R.
dela Cruz-Chuh, Josefa
Poison, Andrew
Flygare, John A.
Howard, Philip W.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9490 - 9507
[6] Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody-Drug Conjugates
Zhang, Donglu
Pillow, Thomas H.
Ma, Yong
dela Cruz-Chuh, Josefa
Kozak, Katherine R.
Sadowsky, Jack D.
Philips, Gail D. Lewis
Guo, Jun
Darwish, Martine
Fan, Peter
Chen, Jingtian
He, Changrong
Wang, Tao
Yao, Hui
Xu, Zijin
Chen, Jinhua
Wai, John
Pei, Zhonghua
Hop, Cornelis E. C. A.
Khojasteh, S. Cyrus
Dragovich, Peter S.
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (11): : 988 - 993
[7] pro-Pyrrolobenzodiazepine (pro-PBD) bioconjugates, the legacy: Design and synthesis of pro-PBD conjugates containing self-immolative substituted disulfide linkers
Vlahov, Iontcho
Qi, Longwu
Santhapuram, Hari K.
Parham, Garth
Wang, Kevin
Vaughn, Jeremy F.
Hahn, Spencer J.
Vetzel, Marilynn
Nelson, Melissa
Reddy, Joseph A.
Leamon, Christopher P.
CANCER RESEARCH, 2019, 79 (13)
[8] Peptide-Cleavable Self-immolative Maytansinoid Antibody-Drug Conjugates Designed To Provide Improved Bystander Killing
Costoplus, Juliet A.
Veale, Karen H.
Qiu, Qifeng
Ponte, Jose F.
Lanieri, Leanne
Setiady, Yulius
Dong, Ling
Skaletskaya, Anna
Bartle, Laura M.
Salomon, Paulin
Wu, Rui
Maloney, Erin K.
Kovtun, Yelena V.
Ab, Olga
Lai, Kate
Chari, Ravi V. J.
Widdison, Wayne C.
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (10): : 1393 - 1399
[9] Cleavable linkers in antibody-drug conjugates
Bargh, Jonathan D.
Isidro-Llobet, Albert
Parker, Jeremy S.
Spring, David R.
CHEMICAL SOCIETY REVIEWS, 2019, 48 (16) : 4361 - 4374
[10] Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates
Zhang, Donglu
Fourie-O'Donohue, Aimee
Dragovich, Peter S.
Pillow, Thomas H.
Sadowsky, Jack D.
Kozak, Katherine R.
Cass, Robert T.
Liu, Liling
Deng, Yuzhong
Liu, Yichin
Hop, Cornelis E. C. A.
Khojasteh, S. Cyrus
DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1156 - 1163

← 1 2 3 4 5 →